Transform to Cognitive Healthcare with IBM Software Defined Infrastructure an...
Executive summary medisapiens-mar 2013
1. Business brief:
Dedicated to realizing the potential of personalized genomics
and helping pharma R&D make fast and clinically predictive
development decisions
Developing ways to utilize the world’s genomics data with easy-
to-use software
Product brief:
OncoGenomics Explorer™ web-based system for analysis and
visualization of multi-dimensional cancer omics data
World’s largest unified database of multi-dimensional biologic
data with clinical data with over 20.000 samples and 300+
distinct cancer types
Enable knowledge-based decisions for clinical trial recruitment
and drug repositioning
See how gene level data correlates with clinical covariates (such as survival or disease
Highlights: grade), cluster samples based on mutation data and discover mutation co-occurrence and
Petabyte –scale data infrastructure harnesses the power of much more.
heterogeneous cancer genomics Big Data Data (mRNA, RNA-
Seq, SNP, methylation, mutation) and a built-in support for
TCGA data
Intuitive UI features gamification elements and fluid, easily Data warehouses
customizable workspace
Powerful analysis tools enable knowledge-based go/no-go
decisions for early drug discovery
Manual curation of clinical
Flexible open API enables seamless incorporation of proprietary sample annotation (eVOC, ICD)
data and data processing algorithms
Pat.pending data integration
Powerful online analysis tools Centralized storage/analysis
Contact person: Rami Kakonen, VP Business Development Fast, localized access
Flexible, user-oriented interface
Contact: rami.kakonen@medisapiens.com
Tel. +358 40 5069944